Anticoagulant-Antidote Pairing Passes 1st Human Safety Test (HealthDay)
14th Nov 2006, 03:40 GMT
A novel medication "system" for heart patients, which first administers an anti-clotting drug and then adds an antidote to neutralize the effect, has passed an initial safety test in humans, researchers announced Monday.
Anticoagulant-Antidote Pairing Passes 1st Human Safety Test (HealthDay) related news:
- Anticoagulant-Antidote Pairing Passes 1st Human Safety Test — WOODTV - Health
- Novel drug-antidote combination shown safe in humans — EurekAlert! - Breaking News
- LIVE: Pakistan v West Indies, 1st Test — cricmania.com
- Clinical Trials Update: Nov. 13, 2006 (HealthDay) — Yahoo! News: Health News
- UPDATE 1-Test Series Pakistan v West Indies scoreboard — Reuters: Sports (Cricket)
- UPDATE 2-Test Series Pakistan v West Indies scoreboard — Reuters: Sports (Cricket)
- Smoking While Pregnant Boosts Baby's Heart Defect Risk (HealthDay) — Yahoo! News: Health News
- Potent Painkiller Found in Human Saliva (HealthDay) — Yahoo! Health: Health News
- Scientists Developing Lung Cancer Breath Test (HealthDay) —
- Pharmacy Program Helps Elderly Take Their Meds (HealthDay) — Yahoo! News: Health News
Latest news from Yahoo! Health: Health News:
- Simple steps can speed heart attack care: study (Reuters)
- Hospitals want faster heart attack care (Associated Press)
- Diabetes threatens many of world's indigenous people (Reuters)
- Fast test catches heart blockages, U.S. study shows (Reuters)
- Children showing hardening of arteries -U.S. study (Reuters)
- Children showing hardening of arteries: U.S. study (Reuters)
- Two Canada professors win right to toke up at work (Reuters)
- Results mixed on Merck's new painkiller (Associated Press)
- Group gives advice on face transplants (Associated Press)
- Diabetes drug may cut heart risks: study (Reuters)